T1	SectionAnnotate 2018 2035	INTERVAL HISTORY:
T2	SectionSkip 2624 4269	Medications the patient states to be taking prior to today's encounter.   Medication Sig    ALPRAZolam (XANAX) 0.25 mg tablet Take 1 tablet (0.25 mg total) by mouth nightly as needed for Sleep.    atorvastatin (LIPITOR) 40 mg tablet Take 1 tablet (40 mg total) by mouth Daily.    diclofenac (VOLTAREN) 1 % GEL gel APPLY TO AFFECTED AREAS TOPICALLY PRN FOR PAIN    DOMPERIDONE, BULK, MISC Take 10 mg by mouth Twice a day.     granisetron (SANCUSO) 3.1 mg/24 hour patch Apply patch at least 24 hrs prior to chemo. Remove minimum of 24 hrs after chemo completion. Patch may be worn up to 7 days    INSULIN ASPART 100 UNIT/ML SUBCUTANEOUS PEN, CONTINUOUS TPN/TF/NPO,     lidocaine-diphenhydramine-maalox (MAGIC MOUTHWASH) 200-25-400-40 mg/30 mL MWSH mouthwash Take 15 mLs by mouth 4 (four) times daily as needed (painful mouth sores & throat pain).    lipase-protease-amylase (CREON) 36,000-114,000- 180,000 unit capsule TAKE 2 CAPSULES BY MOUTH WITH EACH MEAL AND 1 CAPSULE BY MOUTH WITH EACH SNACK. TAKE WITH OR DURING MEAL    multivit with min-folic acid (OMNICAP) 0.4 mg TAB     nitroGLYCERIN 6.5 mg CR capsule Take 6.5 mg by mouth Daily.     ondansetron (ZOFRAN) 8 mg tablet Take 1 tablet three times a day as needed for nausea and vomiting. Start 2 days after last dose of 
 palonosetron (Aloxi) is given.    pantoprazole (PROTONIX) 40 mg EC tablet Take 40 mg by mouth Daily.    pantoprazole 40 mg GrPS     prochlorperazine (COMPAZINE) 10 mg tablet Take 1 tablet (10 mg total) by mouth every 6 (six) hours as needed (nausea and vomiting).    tamsulosin (FLOMAX) 0.4 mg 24 hr capsule Take 1 capsule (0.4 mg total) by mouth Daily.
T3	SectionSkip 4274 4284	ALLERGIES:
T4	SectionAnnotate 4864 4878	Family History
T5	SectionAnnotate 5066 5080	Social History
T6	SectionAnnotate 6192 6216	Social History Narrative
T7	SectionSkip 6533 6558	PHYSICAL EXAM:  Objective
T8	SectionSkip 7773 7789	Laboratory data:
T9	SectionSkip 7792 8414	Lab Results   Component 
 Value Date    WBC Count 7.4 12/27/2018    Neutrophil Absolute Count 4.62 12/27/2018    Hemoglobin 9.4 (L) 12/27/2018    Hematocrit 30.1 (L) 12/27/2018    Platelet Count 351 12/27/2018    Creatinine 0.58 (L) 12/27/2018    Bilirubin, Total 0.4 12/27/2018    Alkaline Phosphatase 305 (H) 12/27/2018    Aspartate transaminase 33 12/27/2018    Alanine transaminase 31 12/27/2018    Albumin, Serum / Plasma 3.0 (L) 11/24/2018    Int'l Normaliz Ratio 1.1 05/29/2018    Sodium, Serum / Plasma 137 11/24/2018    Potassium, Serum / Plasma 3.9 11/24/2018    Calcium, total, Serum / Plasma 8.7 (L) 11/24/2018
T10	SectionSkip 8419 8903	Lab Results   Component Value Date    Cancer Antigen 19-9 900 (H) 12/13/2018    Cancer Antigen 19-9 634 (H) 12/07/2018    Cancer Antigen 19-9 1,625 (H) 11/24/2018    Carcinoembryonic Antigen 8.3 (H) 12/13/2018    Carcinoembryonic Antigen 8.5 (H) 12/07/2018    Carcinoembryonic Antigen 10.6 (H) 11/24/2018     Germline and Molecular testing:  - Patient is a SPINK1 carrier.   - He has variant of unknown significance in FANCG and NF2.    Radiographic data:   No recent imaging reviewed
T11	SectionAnnotate 8907 8927	ASSESSMENT AND PLAN:
T12	PROBLEM 229 259	Adenocarcinoma of the pancreas
T13	TREATMENT 273 282	resection
T14	PROBLEM 293 315	new metastatic disease
T15	PROBLEM 359 379	abdominal discomfort
T16	PROBLEM 384 410	biliary ductal obstruction
T17	TEST 431 438	an ERCP
T18	TREATMENT 443 448	stent
T19	TREATMENT 486 495	a Whipple
T20	ClinicalCondition 500 525	pancreatic adenocarcinoma
T21	PROBLEM 548 575	postoperative complications
T22	PROBLEM 579 596	internal bleeding
T23	TEST 611 635	an additional laparotomy
T24	PROBLEM 644 672	direct invasion of the tumor
T25	TEST 700 714	25 lymph nodes
T26	PROBLEM 759 784	a small bowel obstruction
T27	TREATMENT 807 826	nasogastric suction
T28	TREATMENT 835 841	a port
T29	PROBLEM 883 891	infected
T30	PROBLEM 916 922	sepsis
T31	PROBLEM 928 938	klebsiella
T32	MedicationName 962 967	Cipro
T33	TEST 982 1001	New baseline CT CAP
T34	PROBLEM 1022 1042	new liver metastases
T35	TREATMENT 1056 1071	C1D1 FOLFIRINOX
T36	TEST 1074 1076	CA
T37	PROBLEM 1131 1136	fever
T38	TEST 1148 1150	CT
T39	PROBLEM 1168 1186	any acute findings
T40	PROBLEM 1203 1240	worsening metastatic disease to liver
T41	Radiology 1242 1245	CXR
T42	TEST 1256 1258	UA
T43	TEST 1315 1317	CA
T44	TEST 1362 1364	CT
T45	TEST 1365 1368	CAP
T46	PROBLEM 1397 1409	hepatic mets
T47	PROBLEM 1432 1460	pancreatic ductal dilatation
T48	TEST 1480 1482	CA
T49	TEST 1539 1541	CA
T50	TEST 1585 1587	CT
T51	TEST 1588 1591	CAP
T52	PROBLEM 1600 1615	slight increase
T53	PROBLEM 1631 1641	liver mets
T54	TEST 1663 1669	his CA
T55	PROBLEM 1708 1720	asymptomatic
T56	TREATMENT 1759 1769	FOLFIRINOX
T57	TEST 1790 1792	CA
T58	TEST 1858 1860	CA
T59	TEST 1901 1903	CT
T60	PROBLEM 1918 1937	disease progression
T61	TEST 1939 1941	CA
T62	TREATMENT 1974 1985	Gemcitabine
T63	TREATMENT 1988 1996	Abraxane
T64	Symptom 2146 2165	intermittent fevers
T65	TreatmentType 2189 2198	treatment
T66	PROBLEM 2200 2225	His numbness in his hands
T67	PROBLEM 2405 2425	unsteady on his feet
T68	PROBLEM 2451 2463	more fatigue
T69	TEST 2571 2588	All other systems
T70	TREATMENT 2624 2635	Medications
T71	TREATMENT 2698 2735	Medication Sig    ALPRAZolam (XANAX)
T72	PROBLEM 2812 2817	Sleep
T73	TREATMENT 2823 2845	atorvastatin (LIPITOR)
T74	TREATMENT 2907 2928	diclofenac (VOLTAREN)
T75	TREATMENT 2929 2940	1 % GEL gel
T76	PROBLEM 2983 2987	PAIN
T77	TREATMENT 2992 3015	DOMPERIDONE, BULK, MISC
T78	TREATMENT 3054 3075	granisetron (SANCUSO)
T79	TREATMENT 3103 3108	patch
T80	TREATMENT 3134 3139	chemo
T81	TREATMENT 3172 3188	chemo completion
T82	TREATMENT 3190 3195	Patch
T83	TREATMENT 3225 3239	INSULIN ASPART
T84	TREATMENT 3281 3291	TPN/TF/NPO
T85	TREATMENT 3298 3348	lidocaine-diphenhydramine-maalox (MAGIC MOUTHWASH)
T86	PROBLEM 3440 3459	painful mouth sores
T87	PROBLEM 3462 3473	throat pain
T88	TREATMENT 3480 3511	lipase-protease-amylase (CREON)
T89	TREATMENT 3658 3696	multivit with min-folic acid (OMNICAP)
T90	TREATMENT 3713 3726	nitroGLYCERIN
T91	TREATMENT 3778 3798	ondansetron (ZOFRAN)
T92	PROBLEM 3857 3863	nausea
T93	PROBLEM 3868 3876	vomiting
T94	TREATMENT 3912 3932	palonosetron (Aloxi)
T95	TREATMENT 3947 3970	pantoprazole (PROTONIX)
T96	TREATMENT 4018 4030	pantoprazole
T97	TREATMENT 4047 4075	prochlorperazine (COMPAZINE)
T98	PROBLEM 4157 4163	nausea
T99	PROBLEM 4168 4176	vomiting
T100	TREATMENT 4183 4202	tamsulosin (FLOMAX)
T101	PROBLEM 4318 4333	Known Allergies
T102	ClinicalCondition 4391 4441	COPD (chronic obstructive pulmonary disease) (HCC)
T103	ClinicalCondition 4456 4479	Diabetes mellitus (HCC)
T104	ClinicalCondition 4494 4506	Hypertension
T105	ClinicalCondition 4521 4552	Pancreatic adenocarcinoma (HCC)
T106	ClinicalCondition 4919 4936	Pancreatic cancer
T107	ClinicalCondition 4959 4976	Pancreatic cancer
T108	ClinicalCondition 4998 5015	Pancreatic cancer
T109	ClinicalCondition 5037 5054	Pancreatic cancer
T110	TREATMENT 6480 6500	nicotine replacement
T111	TEST 6576 6582	Vitals
T112	TEST 6603 6605	BP
T113	TEST 6642 6647	Pulse
T114	TEST 6654 6658	Resp
T115	TEST 6665 6669	Temp
T116	TEST 6676 6677	C
T117	TEST 6689 6696	TempSrc
T118	TEST 6698 6713	Temporal   SpO2
T119	TEST 6722 6728	Weight
T120	TEST 6749 6755	Height
T121	PROBLEM 6869 6872	NAD
T122	PROBLEM 6905 6911	rashes
T123	PROBLEM 6915 6922	lesions
T124	PROBLEM 6930 6946	sclera anicteric
T125	PROBLEM 6971 7002	open sores in his buccal mucosa
T126	PROBLEM 7007 7015	erythema
T127	PROBLEM 7016 7021	edema
T128	PROBLEM 7079 7087	erythema
T129	PROBLEM 7092 7098	thrush
T130	PROBLEM 7117 7171	cervical, supraclavicular, or axillary lymphadenopathy
T131	TEST 7200 7210	percussion
T132	TEST 7223 7226	CTA
T133	PROBLEM 7243 7250	wheezes
T134	PROBLEM 7252 7259	rhonchi
T135	PROBLEM 7264 7272	crackles
T136	PROBLEM 7327 7334	murmurs
T137	PROBLEM 7339 7343	rubs
T138	PROBLEM 7348 7355	gallops
T139	PROBLEM 7360 7368	LE edema
T140	PROBLEM 7405 7415	tenderness
T141	PROBLEM 7419 7429	distention
T142	PROBLEM 7434 7437	HSM
T143	PROBLEM 7460 7514	point tenderness at cervical, thoracic or lumbar spine
T144	PROBLEM 7581 7602	slight resting tremor
T145	PROBLEM 7700 7702	HI
T146	PROBLEM 7704 7706	SI
T147	PROBLEM 7708 7722	hallucinations
T148	PROBLEM 7724 7732	paranoia
T149	PROBLEM 7737 7746	delusions
T150	TEST 7818 7823	Value
T151	TEST 7832 7835	WBC
T152	TEST 7836 7841	Count
T153	TEST 7860 7870	Neutrophil
T154	TEST 7871 7885	Absolute Count
T155	TEST 7905 7915	Hemoglobin
T156	TEST 7921 7922	L
T157	TEST 7938 7948	Hematocrit
T158	TEST 7972 7986	Platelet Count
T159	TEST 8005 8015	Creatinine
T160	TEST 8039 8048	Bilirubin
T161	TEST 8050 8055	Total
T162	TEST 8074 8094	Alkaline Phosphatase
T163	TEST 8117 8139	Aspartate transaminase
T164	TEST 8157 8177	Alanine transaminase
T165	TEST 8195 8202	Albumin
T166	TEST 8204 8209	Serum
T167	TEST 8212 8218	Plasma
T168	TEST 8241 8246	Int'l
T169	TEST 8247 8255	Normaliz
T170	TEST 8256 8261	Ratio
T171	TEST 8280 8286	Sodium
T172	TEST 8288 8293	Serum
T173	TEST 8296 8302	Plasma
T174	TEST 8321 8330	Potassium
T175	TEST 8332 8337	Serum
T176	TEST 8340 8346	Plasma
T177	TEST 8365 8372	Calcium
T178	TEST 8381 8386	Serum
T179	TEST 8389 8395	Plasma
T180	TEST 8457 8463	Cancer
T181	TEST 8464 8471	Antigen
T182	TEST 8499 8513	Cancer Antigen
T183	TEST 8541 8555	Cancer Antigen
T184	TEST 8585 8609	Carcinoembryonic Antigen
T185	TEST 8632 8656	Carcinoembryonic Antigen
T186	TEST 8679 8703	Carcinoembryonic Antigen
T187	PROBLEM 8774 8790	a SPINK1 carrier
T188	TEST 8856 8873	Radiographic data
T189	TEST 8880 8894	recent imaging
T190	ClinicalCondition 9084 9114	Adenocarcinoma of the pancreas
T191	TREATMENT 9128 9137	resection
T192	PROBLEM 9148 9170	new metastatic disease
T193	PROBLEM 9175 9201	#pancreatic adenocarcinoma
T194	TREATMENT 9238 9248	FOLFIRINOX
T195	TREATMENT 9272 9288	2nd line therapy
T196	TREATMENT 9294 9305	Gemcitabine
T197	TREATMENT 9308 9316	Abraxane
T198	TEST 9333 9341	His labs
T199	PerformanceStatus 9346 9348	PS
T200	TREATMENT 9394 9402	C2D1 Gem
T201	TREATMENT 9403 9408	Abrax
T202	TREATMENT 9459 9476	his Abraxane dose
T203	PROBLEM 9494 9519	his peripheral neuropathy
T204	PROBLEM 9547 9565	grade 1 neuropathy
T205	TREATMENT 9584 9602	dose modifications
T206	TEST 9618 9626	His labs
T207	TEST 9631 9633	PS
T208	Radiology 9686 9693	CT scan
T209	PROBLEM 9730 9737	#Nausea
T210	PROBLEM 9738 9746	vomiting
T211	TREATMENT 9777 9789	chemotherapy
T212	TREATMENT 9806 9811	Aloxi
T213	TREATMENT 9853 9870	granisetron patch
T214	TREATMENT 9897 9906	compazine
T215	TREATMENT 9916 9928	IV hydration
T216	TREATMENT 9997 10013	cannabis product
T217	PROBLEM 10019 10051	#pancreatic enzyme insufficiency
T218	TREATMENT 10065 10070	Creon
T219	PROBLEM 10185 10191	SPINK1
T220	PROBLEM 10229 10242	TWO mutations
T221	PROBLEM 10280 10286	SPINK1
T222	PROBLEM 10319 10345	some familial pancreatitis
T223	PROBLEM 10364 10381	pancreatic cancer
T224	PROBLEM 10389 10398	UE tremor
T225	PROBLEM 10401 10424	bilateral foot drop L>R
T226	ProcedureName 10438 10441	EMG
T227	TEST 10466 10475	foot drop
T228	RadPathResult 10516 10600	bilateral, predominantly demyelinating peroneal neuropathies across the fibular head
T229	RadPathResult 10603 10658	Demyelinating peroneal neuropathies at the fibular head
T230	Symptom 10747 10758	weight loss
T231	PROBLEM 10984 11000	any new symptoms
T232	PROBLEM 11194 11206	the symptoms
T233	TREATMENT 11208 11222	treatment plan
T234	SectionSkip 2624 3909;3912 4269	Medications the patient states to be taking prior to today's encounter.   Medication Sig    ALPRAZolam (XANAX) 0.25 mg tablet Take 1 tablet (0.25 mg total) by mouth nightly as needed for Sleep.    atorvastatin (LIPITOR) 40 mg tablet Take 1 tablet (40 mg total) by mouth Daily.    diclofenac (VOLTAREN) 1 % GEL gel APPLY TO AFFECTED AREAS TOPICALLY PRN FOR PAIN    DOMPERIDONE, BULK, MISC Take 10 mg by mouth Twice a day.     granisetron (SANCUSO) 3.1 mg/24 hour patch Apply patch at least 24 hrs prior to chemo. Remove minimum of 24 hrs after chemo completion. Patch may be worn up to 7 days    INSULIN ASPART 100 UNIT/ML SUBCUTANEOUS PEN, CONTINUOUS TPN/TF/NPO,     lidocaine-diphenhydramine-maalox (MAGIC MOUTHWASH) 200-25-400-40 mg/30 mL MWSH mouthwash Take 15 mLs by mouth 4 (four) times daily as needed (painful mouth sores & throat pain).    lipase-protease-amylase (CREON) 36,000-114,000- 180,000 unit capsule TAKE 2 CAPSULES BY MOUTH WITH EACH MEAL AND 1 CAPSULE BY MOUTH WITH EACH SNACK. TAKE WITH OR DURING MEAL    multivit with min-folic acid (OMNICAP) 0.4 mg TAB     nitroGLYCERIN 6.5 mg CR capsule Take 6.5 mg by mouth Daily.     ondansetron (ZOFRAN) 8 mg tablet Take 1 tablet three times a day as needed for nausea and vomiting. Start 2 days after last dose of palonosetron (Aloxi) is given.    pantoprazole (PROTONIX) 40 mg EC tablet Take 40 mg by mouth Daily.    pantoprazole 40 mg GrPS     prochlorperazine (COMPAZINE) 10 mg tablet Take 1 tablet (10 mg total) by mouth every 6 (six) hours as needed (nausea and vomiting).    tamsulosin (FLOMAX) 0.4 mg 24 hr capsule Take 1 capsule (0.4 mg total) by mouth Daily.
A1	SectionSkipType T234 medications
T235	SectionSkip 6533 7747	PHYSICAL EXAM:  Objective   Vital Signs:   Vitals:    12/27/18 1058   BP: 133/69  Comment: ALL VST FROM IC   Pulse: 79   Resp: 18   Temp: 36.9 C (98.4 F)   TempSrc: Temporal   SpO2: 100%   Weight: 55.8 kg (123 lb)   Height: 166.6 cm (5' 5.59")  Comment: September 2018 @ *****   PainSc:  0      Pain: 1  ECOG: 0  Constitutional:  WDWN, NAD. +Thin.   Skin: warm, moist. No rashes or lesions  Eyes: sclera anicteric, PERRL, EOMI   HENT: No open sores in his buccal mucosa, no erythema/edema. sinuses nontender, nasal mucosa intact, pharynx without erythema, no thrush   Lymph Nodes: no cervical, supraclavicular, or axillary lymphadenopathy    Respiratory: resonant to percussion throughout, CTA bilaterally, no wheezes, rhonchi, or crackles  Cardiovascular: Normal heart rate, Normal rhythm, No murmurs, No rubs, No gallops. No LE edema   GI: Bowel sounds normal, Soft, No tenderness or distention. No HSM   Musculoskeletal: No point tenderness at cervical, thoracic or lumbar spine, muscular strength equal throughout   Neurologic: +Right arm with slight resting tremor. Alert & oriented x 3, ambulates w/o difficulty, CN II-XII intact.  Psychiatric: Mood stable. No HI, SI, hallucinations, paranoia, or delusions.
A2	SectionSkipType T235 physical_exam
T236	SectionSkip 7751 7815;7818 8414	DIAGNOSTIC STUDIES:   Laboratory data:   Lab Results   Component Value Date    WBC Count 7.4 12/27/2018    Neutrophil Absolute Count 4.62 12/27/2018    Hemoglobin 9.4 (L) 12/27/2018    Hematocrit 30.1 (L) 12/27/2018    Platelet Count 351 12/27/2018    Creatinine 0.58 (L) 12/27/2018    Bilirubin, Total 0.4 12/27/2018    Alkaline Phosphatase 305 (H) 12/27/2018    Aspartate transaminase 33 12/27/2018    Alanine transaminase 31 12/27/2018    Albumin, Serum / Plasma 3.0 (L) 11/24/2018    Int'l Normaliz Ratio 1.1 05/29/2018    Sodium, Serum / Plasma 137 11/24/2018    Potassium, Serum / Plasma 3.9 11/24/2018    Calcium, total, Serum / Plasma 8.7 (L) 11/24/2018
A3	SectionSkipType T236 laboratory
T237	ClinicalCondition 229 259	Adenocarcinoma of the pancreas
A4	ChronicVal T237 non-chronic
T238	Histology 229 243	Adenocarcinoma
R1	TumorDesc TumorDetails:T238 Desc:T237	
T239	TreatmentType 273 282	resection
A5	TreatmentContinuityVal T239 finished
A6	TreatmentTypeVal T239 local
A7	TreatmentIntentVal T239 curative
R2	TreatmentAdministeredForProblem Treatment:T239 Prob:T237	
T240	Metastasis 297 307	metastatic
A8	EpisodeDescription T240 Progression
T241	DiseaseState 297 307	metastatic
A9	DiseaseStateVal T241 progression-recurrence
T242	Symptom 359 379	abdominal discomfort
A10	IsPresentOnFirstCancerDiagnosis T242 yes
A11	IsCausedByDiagnosedCancer T242 yes
A12	ChronicVal T242 non-chronic
A13	ContinuityVal T242 new
T243	ClinicalCondition 384 410	biliary ductal obstruction
A14	ChronicVal T243 non-chronic
A15	ContinuityVal T243 new
T244	Datetime 415 425	March 2018
R3	HappensBefore Arg1:T242 Arg2:T244	
R4	HappensBefore Arg1:T243 Arg2:T244	
T245	ProcedureName 434 438	ERCP
R5	HappensAtOnDuring Arg1:T244 Arg2:T245	
T246	ProcedureName 443 448	stent
A16	IntentVal T246 others
A17	TreatmentTypeVal T246 others
A18	TreatmentCategory T246 Others
R6	HappensAtOnDuring Arg1:T244 Arg2:T246	
R7	TestOrProcedureConductedForProblem Test:T246 Prob:T243	
T247	Datetime 464 474	04/01/2018
T248	ProcedureName 488 495	Whipple
A19	IntentVal T248 treatment-curative
A20	TreatmentTypeVal T248 others
A21	TreatmentCategory T248 Others
A22	IsTumorRemaining T248 unclear
T249	TreatmentType 488 495	Whipple
A23	TreatmentContinuityVal T249 finished
A24	TreatmentTypeVal T249 local
A25	TreatmentIntentVal T249 curative
A26	ChronicVal T20 non-chronic
R8	TreatmentAdministeredForProblem Treatment:T249 Prob:T20	
R9	TestOrProcedureConductedForProblem Test:T248 Prob:T20	
R10	HappensAtOnDuring Arg1:T247 Arg2:T248	
R11	HappensAtOnDuring Arg1:T247 Arg2:T249	
T250	ClinicalCondition 579 596	internal bleeding
A27	ChronicVal T250 non-chronic
A28	ContinuityVal T250 new
R12	ConditionOrTreatmentCausesProblem Treatment:T248 Prob:T250	
T251	ProcedureName 614 635	additional laparotomy
A29	IntentVal T251 others
A30	TreatmentTypeVal T251 local
A31	TreatmentCategory T251 Others
R13	TestOrProcedureConductedForProblem Test:T251 Prob:T250	
T252	LocalInvasion 644 659	direct invasion
A32	EpisodeDescription T252 FirstOccurrence
R14	TestOrProcedureReveals Test:T248 Desc:T252	
T253	Site 682 690	duodenum
R15	SiteOf Arg1:T253 Arg2:T252	
T254	LymphNodeInvolvement 695 702	6 of 25
A33	EpisodeDescription T254 FirstOccurrence
R16	TestOrProcedureReveals Test:T248 Desc:T254	
T255	ProcedureName 807 826	nasogastric suction
A34	IntentVal T255 others
T256	ProcedureName 837 841	port
A35	IntentVal T256 others
T257	ClinicalCondition 761 784	small bowel obstruction
A36	ChronicVal T257 non-chronic
A37	ContinuityVal T257 new
R17	ConditionOrTreatmentCausesProblem Treatment:T248 Prob:T257	
R18	TestOrProcedureConductedForProblem Test:T255 Prob:T257	
T258	ClinicalCondition 883 891	infected
A38	ChronicVal T258 non-chronic
A39	ContinuityVal T258 new
R19	ConditionOrTreatmentCausesProblem Treatment:T256 Prob:T258	
T259	ClinicalCondition 916 938	sepsis with klebsiella
A40	ChronicVal T259 non-chronic
A41	ContinuityVal T259 new
A42	TreatmentContinuityVal T32 finished
A43	TreatmentIntentVal T32 others
A44	TreatmentCategory T32 Others
R20	TreatmentAdministeredForProblem Treatment:T32 Prob:T259	
T260	Radiology 995 1001	CT CAP
A45	IntentVal T260 TreatmentAssessment
T261	Datetime 972 980	05/25/18
T262	Metastasis 1032 1042	metastases
A46	EpisodeDescription T262 Progression
R21	TestOrProcedureReveals Test:T260 Desc:T262	
T263	RadPathResult 1032 1042	metastases
A47	RadPathResultVal T263 Progression
T264	Site 1026 1031	liver
R22	SiteOf Arg1:T264 Arg2:T263	
R23	SiteOf Arg1:T264 Arg2:T262	
R24	ResultOfTest Desc:T263 Test:T260	
R25	HappensAtOnDuring Arg1:T261 Arg2:T260	
T265	Datetime 1046 1054	06/05/18
T266	MedicationRegimen 1061 1071	FOLFIRINOX
A48	TreatmentContinuityVal T266 started
A49	TreatmentTypeVal T266 maintenance
A50	TreatmentIntentVal T266 palliative
T267	MedicationRegimen 1286 1296	FOLFIRINOX
A51	TreatmentContinuityVal T267 continuing
A52	TreatmentTypeVal T267 maintenance
A53	TreatmentIntentVal T267 palliative
T268	Cycles 1056 1060	C1D1
R26	TreatmentDesc Therapy:T268 Desc:T266	
T269	Cycles 1281 1285	C2D1
T270	Cycles 1309 1313	C3D1
T271	Cycles 1346 1350	C4D1
T272	Cycles 1474 1478	C5D1
T273	Cycles 1517 1521	C6D1
T274	Cycles 1533 1537	C7D1
T275	Cycles 1569 1573	C8D1
T276	Cycles 1784 1789	C9D1.
T277	Cycles 1834 1839	C10D1
T278	Cycles 1851 1857	C11D1.
T279	Cycles 1883 1888	C12D1
T280	Cycles 1969 1973	C1D1
T281	Cycles 2009 2014	C1D15
T282	Cycles 2111 2115	C2D1
T283	MedicationRegimen 1759 1769	FOLFIRINOX
A54	TreatmentContinuityVal T283 continuing
A55	TreatmentTypeVal T283 maintenance
A56	TreatmentIntentVal T283 palliative
T284	MedicationRegimen 1974 1996	Gemcitabine + Abraxane
A57	TreatmentContinuityVal T284 continuing
A58	TreatmentTypeVal T284 maintenance
A59	TreatmentIntentVal T284 palliative
T285	Radiology 1148 1150	CT
A60	IntentVal T285 TreatmentAssessment
T286	Radiology 1362 1368	CT CAP
A61	IntentVal T286 TreatmentAssessment
T287	Radiology 1585 1591	CT CAP
A62	IntentVal T287 TreatmentAssessment
T288	Radiology 1901 1907	CT CAP
A63	IntentVal T288 TreatmentAssessment
T289	DiagnosticLabTest 1858 1865	CA 19-9
A64	IntentVal T289 TreatmentAssessment
T290	DiagnosticLabTest 1939 1946	CA 19-9
A65	IntentVal T290 TreatmentAssessment
T291	DiagnosticLabTest 1790 1797	CA 19-9
A66	IntentVal T291 TreatmentAssessment
T292	DiagnosticLabTest 1667 1674	CA 19-9
A67	IntentVal T292 TreatmentAssessment
T293	DiagnosticLabTest 1480 1487	CA 19-9
A68	IntentVal T293 TreatmentAssessment
T294	DiagnosticLabTest 1315 1322	CA 19-9
A69	IntentVal T294 TreatmentAssessment
T295	DiagnosticLabTest 1074 1081	CA 19-9
A70	IntentVal T295 staging
T296	Datetime 1095 1103	06/12/18
T297	LabTestResult 1086 1092	17,090
A71	LabTestResultVal T297 abnormal
R27	ResultOfTest Desc:T297 Test:T295	
T298	LabTestResult 1327 1333	21,247
A72	LabTestResultVal T298 abnormal
T299	LabTestResult 1499 1504	6,040
A73	LabTestResultVal T299 abnormal
T300	LabTestResult 1817 1820	789
A74	LabTestResultVal T300 abnormal
T301	LabTestResult 1868 1871	839
A75	LabTestResultVal T301 abnormal
T302	Datetime 1873 1881	11/15/18
T303	Datetime 1890 1898	11/24/18
T304	Datetime 1959 1967	11/29/18
T305	Datetime 1999 2007	12/13/18
T306	Datetime 1824 1832	10/18/18
T307	Datetime 1841 1849	11/01/18
T308	Datetime 1774 1782	10/03/18
T309	Datetime 1559 1567	09/13/18
T310	Datetime 1576 1583	9/26/18
T311	Datetime 1507 1515	08/16/18
T312	Datetime 1523 1531	08/30/18
T313	Datetime 1464 1472	08/02/18
T314	Datetime 1336 1344	07/19/18
T315	Datetime 1352 1360	08/01/18
T316	Datetime 1271 1279	06/21/18
T317	DiagnosticLabTest 1539 1546	CA 19-9
A76	IntentVal T317 TreatmentAssessment
T318	LabTestResult 1551 1556	1,909
A77	LabTestResultVal T318 abnormal
T319	LabTestResult 1951 1956	1,625
A78	LabTestResultVal T319 abnormal
T320	RadPathResult 1168 1186	any acute findings
A79	NegationModalityVal T320 negated
A80	RadPathResultVal T320 Others
T321	RadPathResult 1203 1212;1224 1231	worsening disease
A81	NegationModalityVal T321 affirmed
A82	RadPathResultVal T321 Progression
T322	RadPathResult 1246 1251	clear
A83	NegationModalityVal T322 negated
A84	RadPathResultVal T322 Others
T323	RadPathResult 1377 1393;1405 1409	decrease in size mets
A85	NegationModalityVal T323 affirmed
A86	RadPathResultVal T323 TreatmentResponse
T324	RadPathResult 1432 1460	pancreatic ductal dilatation
A87	NegationModalityVal T324 affirmed
A88	RadPathResultVal T324 Others
T325	RadPathResult 1600 1615;1637 1641	slight increase mets
A89	NegationModalityVal T325 affirmed
A90	RadPathResultVal T325 Unclear
R28	HappensAtOnDuring Arg1:T265 Arg2:T268	
R29	HappensAtOnDuring Arg1:T265 Arg2:T295	
R30	HappensAtOnDuring Arg1:T296 Arg2:T285	
R31	ResultOfTest Desc:T320 Test:T285	
R32	ResultOfTest Desc:T321 Test:T285	
T326	Symptom 1131 1146	fever of 38.3 C
A91	IsPresentOnFirstCancerDiagnosis T326 no
A92	IsCausedByDiagnosedCancer T326 no
A93	ChronicVal T326 non-chronic
A94	ContinuityVal T326 new
R33	HappensAtOnDuring Arg1:T296 Arg2:T326	
T327	Metastasis 1213 1223	metastatic
A95	EpisodeDescription T327 Progression
T328	Site 1235 1241	liver.
A96	IntentVal T41 others
R34	ResultOfTest Desc:T322 Test:T41	
R35	SiteOf Arg1:T328 Arg2:T321	
R36	HappensAtOnDuring Arg1:T316 Arg2:T269	
R37	TreatmentDesc Therapy:T269 Desc:T267	
T329	Datetime 1299 1307	07/05/18
R38	HappensAtOnDuring Arg1:T270 Arg2:T329	
R39	TreatmentDesc Therapy:T270 Desc:T267	
R40	HappensAtOnDuring Arg1:T314 Arg2:T271	
R41	ResultOfTest Desc:T298 Test:T294	
R42	HappensAtOnDuring Arg1:T315 Arg2:T286	
R43	ResultOfTest Desc:T323 Test:T286	
T330	Site 1397 1404	hepatic
R44	SiteOf Arg1:T330 Arg2:T323	
R45	ResultOfTest Desc:T324 Test:T286	
R46	HappensAtOnDuring Arg1:T313 Arg2:T272	
R47	ResultOfTest Desc:T299 Test:T293	
R48	TreatmentDesc Therapy:T272 Desc:T267	
R49	TreatmentDesc Therapy:T271 Desc:T267	
R50	HappensAtOnDuring Arg1:T311 Arg2:T273	
R51	HappensAtOnDuring Arg1:T312 Arg2:T274	
R52	HappensAtOnDuring Arg1:T309 Arg2:T275	
R53	ResultOfTest Desc:T318 Test:T317	
R54	HappensAtOnDuring Arg1:T317 Arg2:T312	
R55	HappensAtOnDuring Arg1:T310 Arg2:T287	
T332	Site 1631 1636	liver
R56	SiteOf Arg1:T332 Arg2:T325	
R57	ResultOfTest Desc:T325 Test:T287	
T331	LabTestResult 1675 1692	continued to drop
A97	LabTestResultVal T331 abnormal
R58	ResultOfTest Desc:T331 Test:T292	
R59	TreatmentDesc Therapy:T283 Desc:T276	
R60	HappensAtOnDuring Arg1:T308 Arg2:T276	
R61	ResultOfTest Desc:T300 Test:T291	
R62	HappensAtOnDuring Arg1:T306 Arg2:T277	
R63	HappensAtOnDuring Arg1:T307 Arg2:T278	
R64	ResultOfTest Desc:T301 Test:T289	
R65	HappensAtOnDuring Arg1:T307 Arg2:T289	
R66	HappensAtOnDuring Arg1:T308 Arg2:T291	
R67	HappensAtOnDuring Arg1:T302 Arg2:T279	
R68	HappensAtOnDuring Arg1:T303 Arg2:T288	
R69	TreatmentDesc Therapy:T277 Desc:T283	
R70	TreatmentDesc Therapy:T278 Desc:T283	
R71	TreatmentDesc Therapy:T279 Desc:T283	
T333	RadPathResult 1918 1937	disease progression
A98	RadPathResultVal T333 Progression
R72	ResultOfTest Desc:T333 Test:T288	
R73	ResultOfTest Desc:T319 Test:T290	
R74	HappensAtOnDuring Arg1:T304 Arg2:T280	
R75	HappensAtOnDuring Arg1:T303 Arg2:T290	
R76	TreatmentDesc Therapy:T280 Desc:T284	
R77	HappensAtOnDuring Arg1:T305 Arg2:T281	
R78	TreatmentDesc Therapy:T284 Desc:T281	
R79	TreatmentDesc Therapy:T284 Desc:T282	
A99	IsPresentOnFirstCancerDiagnosis T64 no
A100	IsCausedByDiagnosedCancer T64 no
A101	ChronicVal T64 non-chronic
A102	ContinuityVal T64 worsening
A103	TreatmentContinuityVal T65 continuing
A104	TreatmentTypeVal T65 maintenance
A105	TreatmentIntentVal T65 palliative
R80	ConditionOrTreatmentCausesProblem Treatment:T65 Prob:T64	
T334	Duration 2170 2178	4-5 days
R81	HappensAtOnDuring Arg1:T334 Arg2:T64	
T335	Symptom 2204 2212	numbness
A106	IsPresentOnFirstCancerDiagnosis T335 no
A107	IsCausedByDiagnosedCancer T335 no
A108	ChronicVal T335 non-chronic
A109	ContinuityVal T335 improving
T336	Symptom 2334 2338	numb
A110	IsPresentOnFirstCancerDiagnosis T336 no
A111	IsCausedByDiagnosedCancer T336 no
A112	ChronicVal T336 non-chronic
A113	ContinuityVal T336 worsening
T337	Symptom 2456 2463	fatigue
A114	IsPresentOnFirstCancerDiagnosis T337 no
A115	IsCausedByDiagnosedCancer T337 no
A116	ChronicVal T337 non-chronic
A117	ContinuityVal T337 worsening
T338	Symptom 2405 2425	unsteady on his feet
A118	NegationModalityVal T338 negated
T339	Duration 2541 2566	December 30 - January 11.
A119	ChronicVal T102 chronic
A120	ContinuityVal T102 stable
A121	ChronicVal T103 chronic
A122	ContinuityVal T103 stable
A123	ChronicVal T104 chronic
A124	ContinuityVal T104 stable
A125	ChronicVal T105 chronic
A126	ContinuityVal T105 stable
T340	ProcedureName 4636 4653	IR PORT PLACEMENT
A127	IntentVal T340 others
A128	TreatmentTypeVal T340 others
T341	ProcedureName 4708 4725	IR PORT PLACEMENT
A129	IntentVal T341 others
A130	TreatmentTypeVal T341 others
T342	Datetime 4697 4707	05/29/2018
T343	Datetime 4768 4778	05/29/2018
R82	HappensAtOnDuring Arg1:T340 Arg2:T342	
R83	HappensAtOnDuring Arg1:T341 Arg2:T343	
A131	ExperiencerVal T106 family
A132	ExperiencerVal T107 family
A133	ExperiencerVal T108 family
A134	ExperiencerVal T109 family
T344	MaritalStatus 5127 5134	Married
A135	IsStoppedOrContinuing T344 continuing
T345	Tobacco 5490 5503	Former Smoker
A136	IsStoppedOrContinuing T345 stopped
T346	Alcohol 5587 5589	No
A137	NegationModalityVal T346 negated
T347	Drugs 5604 5606	No
A138	NegationModalityVal T347 negated
T348	PhysicalActivity 5628 5632	None
A139	NegationModalityVal T348 negated
T349	LivingCondition 6265 6328	He and his wife are now living with her daughter in ***** *****
A140	IsStoppedOrContinuing T349 continuing
T350	ConsumptionQuantity 6402 6413	0-pack-year
T351	Tobacco 6425 6432	smoking
A141	IsStoppedOrContinuing T351 stopped
R84	ConsumptionQuantityRel Arg1:T350 Arg2:T351	
T352	Alcohol 6514 6527	drink alcohol
A142	IsStoppedOrContinuing T352 continuing
A143	NegationModalityVal T352 negated
T353	Age 8957 8959	71
A144	ChronicVal T190 non-chronic
A145	ContinuityVal T190 stable
T354	Histology 9084 9098	Adenocarcinoma
A146	EpisodeDescription T354 Progression
R85	TumorDesc TumorDetails:T354 Desc:T190	
T355	TreatmentType 9128 9137	resection
A147	TreatmentContinuityVal T355 finished
A148	TreatmentTypeVal T355 local
A149	TreatmentIntentVal T355 curative
T356	DiseaseState 9152 9170	metastatic disease
A150	DiseaseStateVal T356 progression-recurrence
R86	TreatmentAdministeredForProblem Treatment:T355 Prob:T190	
T357	ClinicalCondition 9176 9201	pancreatic adenocarcinoma
A151	ChronicVal T357 non-chronic
A152	ContinuityVal T357 stable
T358	MedicationRegimen 9238 9248	FOLFIRINOX
A153	TreatmentContinuityVal T358 finished
A154	TreatmentTypeVal T358 maintenance
A155	TreatmentIntentVal T358 palliative
T359	MedicationRegimen 9294 9316	Gemcitabine + Abraxane
A156	TreatmentContinuityVal T359 continuing
A157	TreatmentTypeVal T359 maintenance
A158	TreatmentIntentVal T359 palliative
T360	Datetime 9320 9328	11/29/18
R87	BeginsOnOrAt Arg1:T360 Arg2:T359	
T361	Age 102 104	71
A159	PerformanceStatusType T199 Other
T362	MedicationRegimen 9399 9408	Gem/Abrax
A160	TreatmentContinuityVal T362 continuing
A161	TreatmentTypeVal T362 maintenance
A162	TreatmentIntentVal T362 palliative
R88	InclusionCriteriaFor Arg1:T362 Arg2:T199	
T363	Cycles 9394 9398	C2D1
R89	TreatmentDesc Therapy:T363 Desc:T362	
T364	MedicationName 9463 9471	Abraxane
A163	TreatmentContinuityVal T364 continuing
A164	TreatmentTypeVal T364 maintenance
A165	TreatmentIntentVal T364 palliative
A166	TreatmentCategory T364 AntiNeoPlastics
T365	TreatmentDoseModification 9452 9458	reduce
A167	NegationModalityVal T365 hypothetical_in_future
R90	TreatmentDesc Therapy:T365 Desc:T364	
T366	ClinicalCondition 9498 9519	peripheral neuropathy
A168	ChronicVal T366 non-chronic
A169	ContinuityVal T366 worsening
R91	ConditionOrTreatmentCausesProblem Treatment:T364 Prob:T366	
T367	ClinicalCondition 9547 9565	grade 1 neuropathy
A170	ChronicVal T367 non-chronic
A171	ContinuityVal T367 worsening
T368	PerformanceStatus 9631 9633	PS
A172	PerformanceStatusType T368 Other
T369	ClinicalCondition 9622 9626	labs
R92	InclusionCriteriaFor Arg1:T369 Arg2:T362	
R93	InclusionCriteriaFor Arg1:T362 Arg2:T368	
T370	Cycles 9674 9678	C2D1
R94	TreatmentDesc Therapy:T370 Desc:T362	
A173	NegationModalityVal T208 planned_in_future
A174	IntentVal T208 TreatmentAssessment
T371	Cycles 9723 9724	2
T373	ClinicalCondition 9731 9737	Nausea
A177	ContinuityVal T373 improving
T374	ClinicalCondition 9738 9746	vomiting
A178	ChronicVal T374 non-chronic
A179	ContinuityVal T374 improving
R97	ConditionOrTreatmentCausesProblem Treatment:T359 Prob:T373	
R98	ConditionOrTreatmentCausesProblem Treatment:T359 Prob:T374	
T375	TreatmentType 9777 9789	chemotherapy
A176	TreatmentContinuityVal T375 continuing
A180	TreatmentTypeVal T375 maintenance
A181	TreatmentIntentVal T375 palliative
T376	MedicationName 9806 9811	Aloxi
A182	TreatmentContinuityVal T376 continuing
A183	TreatmentTypeVal T376 others
A184	TreatmentIntentVal T376 others
A185	TreatmentCategory T376 Supportive
T377	MedicationName 9814 9819	Emend
A186	TreatmentContinuityVal T377 continuing
A187	TreatmentTypeVal T377 others
A188	TreatmentIntentVal T377 others
A189	TreatmentCategory T377 Supportive
T378	MedicationName 9853 9870	granisetron patch
A190	TreatmentContinuityVal T378 continuing
A191	TreatmentTypeVal T378 others
A192	TreatmentIntentVal T378 others
A193	TreatmentCategory T378 Supportive
T379	MedicationName 9897 9906	compazine
A194	TreatmentContinuityVal T379 continuing
A195	TreatmentTypeVal T379 others
A196	TreatmentIntentVal T379 others
A197	TreatmentCategory T379 Supportive
R99	TreatmentAdministeredForProblem Treatment:T376 Prob:T373	
R100	TreatmentAdministeredForProblem Treatment:T376 Prob:T374	
R102	TreatmentAdministeredForProblem Treatment:T377 Prob:T374	
R103	TreatmentAdministeredForProblem Treatment:T377 Prob:T373	
R101	TreatmentAdministeredForProblem Treatment:T378 Prob:T374	
R104	TreatmentAdministeredForProblem Treatment:T378 Prob:T373	
R105	TreatmentAdministeredForProblem Treatment:T379 Prob:T374	
R106	TreatmentAdministeredForProblem Treatment:T379 Prob:T373	
T380	TreatmentDosage 9871 9877	3.1 mg
T381	Frequency 9877 9886	/24 hours
T382	Frequency 9907 9911	PRN.
T383	Frequency 9955 9958	PRN
R107	TreatmentDesc Therapy:T380 Desc:T378	
R108	Temporal Arg1:T381 Arg2:T378	
R109	Temporal Arg1:T382 Arg2:T379	
T384	MedicationName 9917 9928	V hydration
A198	TreatmentContinuityVal T384 continuing
A199	TreatmentTypeVal T384 others
A200	TreatmentIntentVal T384 others
A201	TreatmentCategory T384 Supportive
T385	MedicationName 9997 10005	cannabis
A202	TreatmentContinuityVal T385 continuing
A203	TreatmentTypeVal T385 others
A204	TreatmentIntentVal T385 others
A205	TreatmentCategory T385 Supportive
R110	Temporal Arg1:T383 Arg2:T384	
R111	TreatmentAdministeredForProblem Treatment:T385 Prob:T374	
R112	TreatmentAdministeredForProblem Treatment:T385 Prob:T373	
T386	ClinicalCondition 10020 10051	pancreatic enzyme insufficiency
A206	ChronicVal T386 non-chronic
A207	ContinuityVal T386 stable
R113	ConditionOrTreatmentCausesProblem Treatment:T190 Prob:T386	
T387	MedicationName 10065 10070	Creon
A208	TreatmentContinuityVal T387 continuing
A209	TreatmentTypeVal T387 others
A210	TreatmentIntentVal T387 others
A211	TreatmentCategory T387 Supportive
T388	TreatmentDosage 10071 10076	2 tab
T389	TreatmentDosage 10086 10091	1 tab
R114	TreatmentDesc Therapy:T388 Desc:T387	
R115	TreatmentDesc Therapy:T389 Desc:T387	
R116	TreatmentAdministeredForProblem Treatment:T387 Prob:T386	
T390	GenomicTestResult 10103 10141	SPINK1 gene mutation: SPINK1: c.101A>G
A212	NegationModalityVal T390 affirmed
A213	GenomicTestType T390 Germline
T391	GenomicTest 10280 10286	SPINK1
A214	NegationModalityVal T391 hypothetical_in_future
A215	ExperiencerVal T391 family
A216	IntentVal T391 screening
A217	GenomicTestType T391 Germline
T392	ClinicalCondition 10324 10345	familial pancreatitis
A218	NegationModalityVal T392 hypothetical_in_future
A219	ExperiencerVal T392 family
R117	TestOrProcedureConductedForProblem Test:T391 Prob:T392	
T393	ClinicalCondition 10364 10381	pancreatic cancer
A220	NegationModalityVal T393 hypothetical_in_future
A221	ExperiencerVal T393 family
R118	TestOrProcedureReveals Test:T391 Desc:T393	
T394	Symptom 10392 10398	tremor
A222	IsPresentOnFirstCancerDiagnosis T394 no
A223	IsCausedByDiagnosedCancer T394 no
A224	ContinuityVal T394 stopped
T395	Symptom 10411 10420	foot drop
A225	IsPresentOnFirstCancerDiagnosis T395 no
A226	IsCausedByDiagnosedCancer T395 no
A227	ContinuityVal T395 stopped
T396	Symptom 10466 10475	foot drop
A228	IsPresentOnFirstCancerDiagnosis T396 no
A229	IsCausedByDiagnosedCancer T396 no
A230	ContinuityVal T396 stopped
T397	Site 10389 10391	UE
T398	Laterality 10387 10388	R
R119	LateralityOfSite Arg1:T398 Arg2:T397	
R120	SiteOf Arg1:T397 Arg2:T394	
T399	Site 10401 10410	bilateral
T400	Laterality 10421 10422	L
T401	Laterality 10423 10424	R
R121	LateralityOfSite Arg1:T400 Arg2:T399	
R122	LateralityOfSite Arg1:T401 Arg2:T399	
R123	SiteOf Arg1:T399 Arg2:T395	
A231	IntentVal T226 others
A232	TreatmentTypeVal T226 others
A233	TreatmentCategory T226 Others
T402	Datetime 10445 10453	09/15/18
R124	HappensAtOnDuring Arg1:T226 Arg2:T402	
R125	TestOrProcedureConductedForProblem Test:T226 Prob:T396	
A234	RadPathResultVal T228 Others
A235	RadPathResultVal T229 Others
A236	NegationModalityVal T230 hypothetical_in_future
R126	ResultOfTest Desc:T229 Test:T226	
R127	ResultOfTest Desc:T228 Test:T226	
T403	Duration 10873 10880	2 weeks
T404	Symptom 10984 11000	any new symptoms
A237	NegationModalityVal T404 hypothetical_in_future
R128	HappensAtOnDuring Arg1:T329 Arg2:T294	
R129	HappensAtOnDuring Arg1:T313 Arg2:T293	
R130	HappensAtOnDuring Arg1:T292 Arg2:T310	
R131	TreatmentDesc Therapy:T273 Desc:T267	
R132	TreatmentDesc Therapy:T274 Desc:T267	
R133	TreatmentDesc Therapy:T275 Desc:T267	
T405	DiseaseState 1918 1937	disease progression
A238	DiseaseStateVal T405 progression-others
T406	Employment 6228 6263	commercial ***** but is now retired
A239	IsStoppedOrContinuing T406 stopped
T407	Metastasis 9152 9162	metastatic
A240	EpisodeDescription T407 Progression
R134	HappensBefore Arg1:T358 Arg2:T360	
T408	Datetime 9769 9776	June 24
R135	HappensAtOnDuring Arg1:T408 Arg2:T375	
A241	NegationModalityVal T375 planned_in_future
R136	ConditionOrTreatmentCausesProblem Treatment:T256 Prob:T259	
R137	ConditionOrTreatmentCausesProblem Treatment:T284 Prob:T64	
R138	ConditionOrTreatmentCausesProblem Treatment:T284 Prob:T336	
R139	ConditionOrTreatmentCausesProblem Treatment:T284 Prob:T335	
A242	NegationModalityVal T376 planned_in_future
A243	NegationModalityVal T377 planned_in_future
R140	HappensBefore Arg1:T408 Arg2:T376	
R141	HappensBefore Arg1:T408 Arg2:T377	
A244	NegationModalityVal T378 planned_in_future
A245	NegationModalityVal T379 planned_in_future
A246	NegationModalityVal T384 planned_in_future
T409	hpi_start 87 89	Mr
T410	hpi_end 2555 2566	January 11.
T411	ap_start 8907 8917	ASSESSMENT
T412	ap_end 11074 11077	me.
R142	BeginsOnOrAt Arg1:T266 Arg2:T265	
R143	EndsOnOrAt Arg1:T304 Arg2:T266	
R144	BeginsOnOrAt Arg1:T304 Arg2:T284	
T372	Datetime 9698 9703	after
R95	HappensAtOnDuring Arg1:T372 Arg2:T371	
R96	HappensAtOnDuring Arg1:T208 Arg2:T372	
